Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers

Critical Care Medicine

Volumn 26, Issue 2, 1998, Pages 260-265

  Hoogenberg, Klaas ^a   Smit, Andries J ^a   Girbes, Armand R J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Dopamine; Effective renal plasma flow; Glomerular filtration rate; Heart rate; Mean arterial pressure; Norepinephrine; Renal vasoconstriction; Sodium excretion; Urine flow

Indexed keywords

DOPAMINE; HIPPURIC ACID; IODINE 125; IODINE 131; IOTALAMIC ACID; NORADRENALIN; PLACEBO; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SINGLE BLIND PROCEDURE; SODIUM EXCRETION; VASOCONSTRICTION;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; NOREPINEPHRINE; REFERENCE VALUES; RENAL PLASMA FLOW, EFFECTIVE; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 0031894332     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199802000-00022     Document Type: Article

References (35)

1. Meadows D, Edwards JD, Wilkins RG, et al: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-666
2. Desjars P, Pinaud M, Potel G, et al: A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-137
3. Martin C, Saux P, Albanèse J, et al: A new look at norepinephrine to treat human hyperdynamic septic shock. Abstr. Anaesthesiology 1987; 67:A648
4. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
5. Martin C, Eon B, Saux P, et al: Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18:282-285
6. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
7. Smythe McC, Nickel JF, Bradley SE: The effect of epinephrine (usp), 1-epinephrine, and I-norepinephrine on glomerular filtration rate, renal plasma flow and the urinary excretion of sodium, potassium and water in normal man. J Clin Invest 1952; 31:499-506
8. Hollenberg NK, Solomon HS, Adams DF, et al: Renal vascular responses to angiotensin and norepinephrine in normal man. Circ Res 1972; 31:750-757
9. Lang CC, Rahman AR, Balfour DJK, et al: Effect of norepinephrine on renal sodium and water handling in euhydrated and overhydrated man. Clin Sci 1993; 85:487-494
10. McDonald RH, Goldberg LI, McNay JL, et al: Effect of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest 1964; 43:1116-1124
11. Smit AJ: Dopamine and the kidney. Neth J Med 1989; 34:47-58
12. Girbes ARJ, Lieverse AG, Smit AJ, et al: Lack of specific renal haemodynamic effects of different doses of dopamine in mechanically ventilated patients after infrarenal aortic surgery. Br J Anaesth 1996; 77:753-757
13. Barnard MJ, Linter SPK: Acute circulatory support. BMJ 1993; 307:35-40
14. Parker MM: The heart in sepsis. In: Textbook of Critical Care. Shoemaker WC, Ayres SM, Grenvik A, et al (Eds). Philadephia, WB Saunders, 1995, pp 596-304
15. Schaer G, Fink MP, Parillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492-496
16. Richer M, Robert S, Lebel M: Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 1996; 24:1150-1154
17. Donker AJM, Van der Hem GK, Sluiter WJ, et al: A radioisotope method for simultaneous determination of the glomerular filtration rate and effective renal plasma flow. Neth J Med 1977; 20:97-103
18. Hoogenberg K, Girbes ARJ, Stegeman CA, et al: Influence of ambient plasma norepinephrine on renal haemodynamics in Type 1 (insulin-dependent) diabetic patients and healthy subjects. Scand J Lab Invest 1995; 55:15-22
19. Hoogenberg K, Sluiter WJ, Van Haeften TW, et al: No difference in renal haemodynamic and albuminuric response to noradrenaline in IDDM and healthy subjects. Abstr. Diabetologia 1996; 39(Suppl 1):A294
20. Visscher CA, De Zeeuw D, De Jong PE, et al: Drug induced changes in renal hippurate clearance as a measure of renal blood flow. Kidney Int 1995; 48:1617-1623
21. Edwards RM: Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 1983; 244:F526-F534
22. Edwards RM: Response of isolated renal arterioles to acetylcholine, dopamine, and bradykinin. Am J Physiol 1985; 248:F183-F189
23. Goldberg LI: Dopamine and new dopamine analogs: Receptors and clinical applications. J Clin Anesth 1988; 1:66-74
24. Maddox DA, Brenner BM: Glomerular ultrafiltration. In: The Kidney. Brenner BM, Rector FC (Eds). Philadephia, WB Saunders, 1996, pp 286-333
25. Meyers BD, Deen WM, Brenner BM: Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 1975; 37:101-110
26. Hollenberg NK, Adams DF, Mendell P, et al: Renal vascular responses to dopamine: Haemodynamic and angiographic observations in normal man. Clin Sci Mol Med 1973; 45:733-742
27. Aperia A, Bertorello A, Seri I: Dopamine causes inhibition of NaKATPase from rat proximal tubule segments. Am J Physiol 1987; 252:F39-F45
28. Smit AJ, Meijer S, Wesseling H, et al: The effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease. Clin Sci 1988; 75:421-428
29. Conger JD, Robinette JB, Guggenheim SJ: Effect of acetylcholine on the early phase of reversible norepinephrine-induced acute renal failure. Kidney Int 1981; 19:399-409
30. Lherm T, Troché G, Rossignol M: Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 1996; 22:213-219
31. Girbes ARJ, Patten MT, McCloskey BV, et al: The renal and neurohumoral effects of the addition of low-dose dopamine septic critically-ill patients. Abstr. Intensive Care Med 1996; 22(Suppl 3):S391
32. Flancbaum L, Choban P, Dasta J: Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994; 22:61-66
33. Duke GJ, Briedis JH, Weaver RA: Renal support in critically ill patients: Low-dose dopamine or low-dose dobutamine? Crit Care Med 1994; 22:1919-1925
34. Baldwin L, Henderson A, Hickman P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994; 120:744-747
35. Chertow GM, Sayegh MH, Allgren RL, et al: Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Am J Med 1996; 101:49-53